• / Free eNewsletters & Magazine
  • / My Account
Home>Ebola vaccine from Glaxo passes early trials

Ebola vaccine from Glaxo passes early trials

3party Content

Wed, 26 Nov 2014

A possible Ebola vaccine under development by GlaxoSmithKline PLC (UK:GSK) (GSK) and various U.S. government health agencies has shown positive results in a phase-1 trial, according to findings published Wednesday. The trial involves human volunteers and is mostly meant to assess any possible side
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.